Dr. Stanley Riddell, Seattle's Fred Hutch (IMAGE)
Caption
Dr. Stanley Riddell, an immunotherapy researcher and oncologist at Seattle's Fred Hutchinson Cancer Research Center, will present an update on new adoptive T-cell strategies at the annual meeting of the American Association for the Advancement of Science in Washington, D.C. His presentation will be part of a symposium on the promise and progress of T-cell therapy to fight human diseases. For more than 25 years, Riddell has pioneered experimental therapies that modify and empower the immune system to effectively treat cancers and infectious diseases.
Credit
Fred Hutch News Service
Usage Restrictions
None
License
Licensed content